Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New genetic groups of FMDV discovered
Scientists say there could be more novel FMDV genotypes that remain un-sampled and should now be examined to help aid FMD control.
More novel genotypes could exist, Pirbright says

Scientists have discovered two new genetic groups of foot-and-mouth disease virus (FMDV).

There are seven serotypes of FMDV, of which type O, A, SAT 1, SAT 2 and SAT 3 are currently circulating in Africa.

A research team from the Pirbright Institute studied the genetic material of FMDV samples from eastern and southern Africa. They found that while the newly discovered genotypes belong to the SAT serotype, they have distinct genetic traits that are not shared with other SAT viruses.

It is thought that the new virus groups may be representative of viruses that existed before the Great African Rinderpest Pandemic in 1887-1897, which caused a mass die-off of cattle and African buffalo.

This is likely to have caused the extinction of many FMDV strains that were circulating at the time, leaving only small ‘pockets’ of FMDV in isolated buffalo populations.

After the rinderpest pandemic ended, scientists speculate that serotypes O and A were re-introduced into Africa from other continents through livestock imports. Meanwhile SAT serotypes are thought to have re-emerged from the clusters of African buffalo that survived the pandemic.

Novel strains identified in the recent study are believed to contain genetic signatures of the FMD viruses that existed before the pandemic.

According to the research team, the study suggests there could be more novel FMDV genotypes that remain un-sampled and should now be examined to help aid FMD control.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.